The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Secondary outcomes by prior definitive treatment (tx) in patients (pts) with high-risk biochemically recurrent prostate cancer (hrBCR) treated with enzalutamide (enza) plus leuprolide (combo): EMBARK post hoc analysis.
 
Neal Shore
Employment - GenesisCare
Consulting or Advisory Role - Accord Research; Alessa Therapeutics; Amgen; Antev; Arquer Diagnostics; Asieris Pharmaceuticals; Astellas Pharma; AstraZeneca; Aura Biosciences; Bayer; Bioprotect; Bristol-Myers Squibb/Sanofi; CG Oncology; Clarity Pharmaceuticals; Dendreon; Exact Imaging; Ferring; Fize Medical; Glytherix; InVitae; Janssen Scientific Affairs; Lantheus Medical Imaging; Lilly; MDxHealth; Medivation/Astellas; Merck; Minomic; Myriad Genetics; Novartis; Peerview; Pfizer; Photocure; PlatformQ Health; Promaxo; Propella Therapeutics; Protara Therapeutics; Sanofi; Siemens; Speciality Networks; Sumitomo Pharma Oncology; Telix Pharmaceuticals; Tolmar; Tutelix; Urogen pharma
Research Funding - Abbvie; Advantagene; Amgen; Aragon Pharmaceuticals; Astellas Pharma; AstraZeneca; Bayer; Boston Scientific; Bristol-Myers Squibb/Pfizer; CG Oncology; Clovis Oncology; Dendreon; DisperSol; Endocyte; Exact Imaging; Exelixis; Ferring; FKD Therapies; FORMA Therapeutics; Foundation Medicine; Genentech; Guardant Health; InVitae; Istari Oncology; Janssen; Jiangsu Yahong Meditech; MDxHealth; Medivation; Merck; MT Group; Myovant Sciences; Myriad Genetics; Novartis; Nymox; OncoCellMDx; ORIC Pharmaceuticals; pacific edge; Palette Life Sciences; Pfizer; Plexxikon; POINT Biopharma; Propella Therapeutics; Propella Therapeutics; RhoVac; Sanofi; SeaGen; Sesen Bio; Steba Biotech; Theralase; Tolmar; Urogen pharma; Urotronic; US Biotest; Vaxiion; Veru; Zenflow
 
Martin Gleave
Stock and Other Ownership Interests - Sustained Therapeutics
Honoraria - AbCellera; Astellas Pharma; AstraZeneca; Bayer; Gandeeva; Janssen; Pfizer
Consulting or Advisory Role - AbCellera; Astellas Pharma; AstraZeneca; Bayer; Gandeeva Therapeutics; Janssen; Pfizer
Research Funding - Astellas Pharma; Bayer; Janssen
Patents, Royalties, Other Intellectual Property - ST-CP; ST-POP
 
Ugo De Giorgi
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Clovis Oncology; Dompé Farmaceutici; Eisai; Ipsen; Janssen; Merck; MSD; Novartis; Pfizer; PharmaMar
Research Funding - AstraZeneca (Inst); Roche (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - AstraZeneca/Daiichi Sankyo; Ipsen; Merck; Pfizer
 
Antti Rannikko
Honoraria - Kaiku Health
Consulting or Advisory Role - AstraZeneca; Bayer; Janssen; Nanoform; Orion
Speakers' Bureau - AstraZeneca
Research Funding - AstraZeneca
 
Swetha Sridharan
Travel, Accommodations, Expenses - Cost of attendance at ASTRO 2023 given to department I work in (Inst)
 
Klaus Brasso
No Relationships to Disclose
 
Henry Woo
Stock and Other Ownership Interests - Health Analytics Holdings Pty Ltd
Consulting or Advisory Role - Ferring
Speakers' Bureau - Astellas Pharma; Bayer; Boston Scientific; Olympus
Research Funding - Astellas Pharma; Boston Scientific; Janssen
 
Antonio Gómez Caamaño
Consulting or Advisory Role - Astellas Pharma; Bayer/MonsantoBayer; Janssen
Speakers' Bureau - Astellas Pharma; Bayer; Janssen
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Janssen
 
Luke Nordquist
Stock and Other Ownership Interests - Clarity Pharmaceuticals
Travel, Accommodations, Expenses - Fusion Pharmaceuticals
 
Yiyun Tang
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Ruslan Croitoru
Employment - Astellas Pharma
 
Matt Rosales
Employment - Astellas Pharma
Stock and Other Ownership Interests - Astellas Pharma
 
Matko Kalac
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
Consulting or Advisory Role - Guidepoint Global; Seagen
Speakers' Bureau - Kyowa Kirin International
 
Olivier Peraud
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Fong Wang
Employment - Exelixis; Pfizer
Stock and Other Ownership Interests - Exelixis; Pfizer
 
Stephen Freedland
Employment - Genomic Health (I)
Stock and Other Ownership Interests - Caper Labs; Hessian Labs
Consulting or Advisory Role - A3P Biomedical; Astellas Pharma; AstraZeneca; Bayer; Caper Labs; Clovis Oncology; Dendreon; Exact Sciences; Exosome Diagnostics; Ferring; Hessian Labs; Janssen Biotech; Lilly; LynxDx; Merck; Myovant Sciences; Novartis; Pfizer; Sanofi; Tempus; Tolmar
Speakers' Bureau - Astellas Pharma; AstraZeneca; Pfizer; Sanofi
Research Funding - Bayer (Inst); Diasorin; GenomeDx (Inst); Janssen Biotech (Inst); MDxHealth (Inst); Merck; Myriad Genetics (Inst); OPKO Diagnostics (Inst); Progenika (Inst)
Travel, Accommodations, Expenses - Sanofi